Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

Hearing loss, cisplatin-induced, susceptibility to

MONDO:0013213

Also known as: CIHL, hearing loss, cisplatin-induced, susceptibility to

1 clinical trial for this condition and its sub-types, 1 tagged with Hearing loss, cisplatin-induced, susceptibility to itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inherited disease susceptibility (1316)

Including sub-types (1) Tagged with Hearing loss, cisplatin-induced, susceptibility to (1)

Trials to join now! 1

Cholesterol drug may shield ears from chemo damage

Symptom relief Recruiting now

This study tests whether atorvastatin, a widely used cholesterol medication, can reduce hearing loss caused by cisplatin chemotherapy in people with head and neck cancer. About 224 adults will be randomly assigned to take atorvastatin or a placebo daily during and for three month…

Phase 2 • Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Symptom relief

Last updated Sep 04, 2026 00:00 UTC